Display Settings:

Format

Send to:

Choose Destination
    Neurobiol Aging. 2011 Aug;32(8):1528-9. Epub 2009 Sep 26.

    Gigaxonin mutation analysis in patients with NIFID.

    Source

    CHUL Research Centre and Department of Anatomy and Physiology, Laval University, Québec, Canada.

    Abstract

    Neuronal intermediate filament inclusion disease (NIFID) is a frontotemporal lobar degeneration (FTLD) characterized by frontotemporal dementia (FTD), pyramidal and extrapyramidal signs. The disease is histologically characterized by the presence of abnormal neuronal cytoplasmic inclusions (NCIs) which contain α-internexin and other neuronal intermediate filament (IF) proteins. Gigaxonin (GAN) is a cytoskeletal regulating protein and the genetic cause of giant axonal neuropathy. Since the immunoreactive profile of NCIs in NIFID is similar to that observed in brain sections from Gan(Δex1/Δex1) mice, we speculated that GAN could be a candidate gene causing NIFID. Therefore, we performed a mutation analysis of GAN in NIFID patients. Although the NCIs of NIFID and Gan(Δex1/Δex1) mice were immunohistochemically similar, no GAN variant was identified in DNA obtained from well-characterized cases of NIFID.

    Copyright © 2009 Elsevier Inc. All rights reserved.

    PMID:
    19782434
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2987523
    Free PMC Article

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk